MoonLake Immunotherapeutics (MLTX)
45.56
-1.20
(-2.57%)
USD |
NASDAQ |
Nov 04, 13:21
MoonLake Immunotherapeutics Total Assets (Quarterly): 544.88M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 544.88M |
| March 31, 2024 | 564.12M |
| December 31, 2023 | 526.54M |
| September 30, 2023 | 500.22M |
| June 30, 2023 | 506.62M |
| Date | Value |
|---|---|
| March 31, 2023 | 66.80M |
| December 31, 2022 | 76.84M |
| September 30, 2022 | 88.59M |
| June 30, 2022 | 98.43M |
| December 31, 2021 | 9.682M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.682M
Minimum
Dec 2021
564.12M
Maximum
Mar 2024
298.27M
Average
299.33M
Median
Total Assets (Quarterly) Benchmarks
| Novartis AG | 103.52B |
| AC Immune SA | 264.24M |
| CRISPR Therapeutics AG | 2.340B |
| Addex Therapeutics Ltd | 15.24M |
| NLS Pharmaceutics Ltd | 1.194M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.85M |
| Shareholders Equity (Quarterly) | 520.66M |